Abbott rises on Google Health tie-up for AI-powered glucose insights

Abbott Laboratories

11/08/2026 14:10

** Shares of medical device maker Abbott ABT.N rise 1.4% to $110.17 premarket
** Co says it will integrate glucose data from its Lingo wearable with the Google Health app, allowing users to view blood sugar trends alongside other health and wellness metrics
** Lingo is Abbott's over-the-counter continuous glucose monitor for people without diabetes that helps track how food, exercise, sleep and stress affect blood sugar levels
** Co says Google's Health Coach will use Lingo data to provide personalized AI-driven recommendations on nutrition, activity, sleep and recovery
** Abbott and Google will conduct what Abbott called one of the largest real-world metabolic health studies, combining glucose, wearable, laboratory and survey data
** Lingo integrations will begin rolling out in the Google Health app later this year
** As of last close, stock down ~13% YTD

 (Reporting by Sahil Pandey in Bengaluru)
 ((Sahil.Pandey@thomsonreuters.com))